Medtech executives in 2026 are anticipated to navigate significant changes driven by rapid innovation and evolving care delivery models. Key developments include:
-
Portfolio Re-Construction: Companies are shifting focus towards high-growth therapeutic areas like pulsed field ablation and neuromodulation while restructuring to manage margin pressures. This involves divesting underperforming assets and optimizing operations to allocate capital for growth.
-
Shifts in Care Delivery: The introduction of over 500 procedures to ambulatory surgery centers (ASCs) could reshape the medtech landscape, necessitating tailored commercial strategies and product adaptations for a new customer base that requires streamlined workflows and rapid patient turnover.
-
Strengthening Data Governance with AI: As AI becomes integral to operations, companies must prioritize data governance and talent to fully utilize AI’s potential while ensuring compliance and safety. This will likely lead to increased consolidation among those unable to scale effectively.
In summary, medtech firms that adjust their investment strategies, adapt to outpatient care trends, and enhance data capabilities will be better positioned for success.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.deloitte.com/us/en/Industries/life-sciences-health-care/blogs/health-care/three-key-trends-likely-to-shape-medtech.html
